Schedule of screening, measurement and clinical data collection
| Inspection items | Study period | ||
| Screening period | Measurement and clinical data collection | ||
| Initial assessment of patients | ⅹ | ||
| Signing the informed consent form | ⅹ | ||
| Demographic data collection | ⅹ | ||
| Medical history data collection | ⅹ | ||
| Routine blood test | ⅹ | ||
| Liver function | ⅹ | ||
| Blood coagulation function | ⅹ | ||
| Blood lipid | ⅹ | ||
| Detection of AFP, DCP and AFP-L3 | ⅹ | ||
| Viral hepatitis type B testing | Serum markers of HBV | ⅹ | |
| Concentration of HBV DNA | ⅹ | ||
| Viral hepatitis type C testing | Serum markers of HCV | ⅹ | |
| Concentration of HCV DNA | ⅹ | ||
| Imaging tests of the liver | ⅹ | ||
| Transabdominal ultrasound | ⅹ | ||
| Sample collection for blood polygene methylation testing | ⅹ | ||
| Detection of blood polygene methylation | ⅹ | ||
AFP, α-fetoprotein; AFP-L3, the Lens culinaris agglutinin A-reactive fraction of AFP; DCP, des-γ-carboxy-prothrombin; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus.